World's Best Scientists 2026 revealed!
Oncotarget
H-index 29

Oncotarget

1949-2553

Published by: Impact Journals LLC

https://www.oncotarget.com/

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 852 352 313 25

Additional Metrics

Number of Best Scientists*: 694
Documents by Best Scientists*: 520
Top 100 Ranked Scientists*: 16
SCIMAGO H-index: 192
SCIMAGO SJR: 0.785
Impact Factor: N/A

Overview

Top Research Topics at Oncotarget?

The objective of the journal is to combine knowledge in the areas of Cancer research, Internal medicine, Cancer, Oncology and Immunology. The studies on Cancer research discussed can also contribute to research in the domains of Cell growth, Cancer cell, Apoptosis, Pathology and Metastasis. It holds forums on Cell growth that merges themes from other disciplines such as Cell cycle and Downregulation and upregulation.

The main emphasis of it is the research on Pathology, emphasizing the topic of Immunohistochemistry. It centers on topics in Metastasis, with a focus on Epithelial–mesenchymal transition. Oncotarget explores topics in Internal medicine which can be helpful for research in disciplines like Gastroenterology, Endocrinology and Surgery.

microRNA and Bioinformatics are some topics wherein Cancer research discussed in the journal have an impact. Topics in Oncology explored in the journal were investigated in conjunction with research in Biomarker (medicine), Colorectal cancer, Chemotherapy and Hazard ratio. In Oncotarget, Protein kinase B, PI3K/AKT/mTOR pathway and Signal transduction are investigated in conjunction with one another to address concerns in Immunology research.

  • Cancer research (40.84%)
  • Internal medicine (32.10%)
  • Cancer (23.73%)

What are the most cited papers published in the journal?

  • Inflammatory responses and inflammation-associated diseases in organs (924 citations)
  • Combination therapy in combating cancer. (622 citations)
  • Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients (585 citations)

Research areas of the most cited articles at Oncotarget:

The most cited articles primarily tackle Cancer research, Cancer, Internal medicine, Immunology and Oncology. The most cited publications explore topics in Cancer research which can be helpful for research in disciplines like Cell growth, Cancer cell, Pathology, microRNA and Metastasis. Endocrinology and Surgery are some topics wherein Internal medicine research discussed in the published papers has an impact.

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Oncotarget (based on the number of publications) are:

  • Robert M. Hoffman (50 papers) absent at the last edition,
  • Razelle Kurzrock (48 papers) absent at the last edition,
  • James A. McCubrey (45 papers) absent at the last edition,
  • David S. Hong (40 papers) absent at the last edition,
  • Wei Zhang (39 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Oncotarget (based on the number of publications) are:

  • Shanghai Jiao Tong University (712 papers) published 1 paper at the last edition, 1 less than at the previous edition,
  • Fudan University (707 papers) published 1 paper at the last edition,
  • Sun Yat-sen University (655 papers) published 1 paper at the last edition, 2 less than at the previous edition,
  • University of Texas MD Anderson Cancer Center (629 papers) published 11 papers at the last edition, 6 less than at the previous edition,
  • Nanjing Medical University (595 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 20.54% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 11.80% were posted by at least one author from the top 10 institutions publishing in the journal. Another 2.81% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 10.11% of all publications and 75.28% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

How to Become a Research Contributor to Oncotarget


Becoming a research contributor to Oncotarget requires thorough understanding and practice in the fields of Cancer research, Internal medicine, Oncology, and Immunology among others. Acquiring an in-depth knowledge in these disciplines often necessitates obtaining a higher level of education, for example, becoming a nurse practitioner. The educational and experiential requirements may vary depending on the region or the specific area of specialization.

If you are based in Delaware, for instance, there are specific steps that you need to take into account. Learn more about these prerequisites by checking the nurse practitioner education requirements in Delaware.

Once equipped with the necessary knowledge and skills, it is advisable to stay updated with the latest advancements in the relevant fields. Regular engagement with Oncotarget publications can help develop an understanding of the type of research that is given emphasis in the journal. This can be instrumental in shaping the direction of your own research to ensure it aligns with the journal's focus areas.

Fostering professional relationships with current contributors and editors can also enhance chances of getting published in Oncotarget. Networks can provide valuable insights into your research and potentially advocate for your work during the review process.

Lastly, remember that perseverance and commitment to growth are key. The path to becoming a research contributor can be rigorous, but the outcome is both professionally rewarding and crucial to the advancement of medicine.

Top Publications

  • Acute promyelocytic leukemia (APL): a review of the literature.

    Joaquin J. Jimenez;Ravinder S. Chale;Andrea C. Abad;Andrew V. Schally

    (2020)
    93 Citations
  • Exercise reduces immune suppression and breast cancer progression in a preclinical model

    Erik Wennerberg;Claire Lhuillier;Marissa D. Rybstein;Kyle Dannenberg

    (2020)
    90 Citations
  • Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer

    Anders Handrup Kverneland;Magnus Pedersen;Marie Christine Wulff Westergaard;Morten Nielsen

    (2020)
    76 Citations
  • Tumor mutational burden as a predictor of immunotherapy response in breast cancer.

    Tess A O'Meara;Sara M Tolaney

    (2021)
    74 Citations
  • Phase I study of vemurafenib in children with recurrent or progressive BRAFV600E mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002).

    Theodore Nicolaides;Kellie J. Nazemi;John Crawford;Lindsay Kilburn

    (2020)
    63 Citations
  • Prognostic and predictive factors in pancreatic cancer.

    Emanuela Dell’Aquila;Claudia Angela Maria Fulgenzi;Alessandro Minelli;Fabrizio Citarella

    (2020)
    61 Citations
  • Cancer prevention with rapamycin

    (2023)
    51 Citations
  • Circulating tumor DNA analysis in the era of precision oncology.

    Rabih Said;Nicolas Guibert;Geoffrey R. Oxnard;Apostolia M. Tsimberidou

    (2020)
    44 Citations
  • Efficacy of osimertinib against EGFRvIII+ glioblastoma.

    Gustavo Chagoya;Shawn G. Kwatra;Shawn G. Kwatra;Cory W. Nanni;Callie M. Roberts

    (2020)
    43 Citations
  • Mifamurtide and TAM-like macrophages: effect on proliferation, migration and differentiation of osteosarcoma cells

    Francesca Punzo;Giulia Bellini;Chiara Tortora;Daniela Di Pinto

    (2020)
    41 Citations

Related Online Degrees & Career Pathways

Exploring Medicine in the USA opens doors to various related online degrees that can complement or serve as alternative career paths. For students interested in foundational sciences, pursuing a bs in biology online provides a flexible and accelerated way to build critical knowledge essential for medical studies.

For those drawn to patient care but seeking quicker entry into the healthcare workforce, an asn program online offers accessible training to become a registered nurse. This path can be a stepping stone toward advanced nursing roles or even medical school later.

Nutrition plays a vital role in health, making a nutritionist degree online a practical option for those interested in wellness and preventive medicine. This degree supports careers in dietetics, public health, or private consultation.

For leadership ambitions within healthcare systems, studying a Master of Health Administration is crucial. Prospective students should consider the number of cahme accredited mha programs available online to ensure quality education that meets industry standards.

Best Scientists Contributing to This Journal

Recently Published Articles